In the ever-evolving compliance landscape for life sciences companies, it is critical to stay abreast of current trends and develop best practices to assess and mitigate risks.

Join our partner Joy Dowdle and senior associate Jesselyn Pe as they speak with industry professionals David Ralston, Senior Vice President, Commercial Legal and Healthcare Compliance at Taysha Gene Therapies and Natasha Trifun, Executive Director, Head of Compliance, R&D, Global Medical, External Funding & Global Functions at Alexion, about current issues, trends, and industry best practices in navigating the unique risks related to clinical trials and other research activities.

Our Diverse Voices in Life Sciences series is focused on providing a unique experience to gain access to our panelists' insights and explore areas of most interest to you. Please be sure to mark your calendar for our next installment, which will take place on October 18 and focus on the impacts of ESG on the Life Sciences industry. One hour of General CLE credit will be applied for.

All webinars

• Navigating Compliance Risks in Clinical Trials (September 2022)
• Current Issues, Best Practices, and Strategies for Compliance in R&D and Medical Affairs (May 2022)
• Life Sciences Innovation: New Opportunities, New Challenges (November 2021)
• Joining Forces to Advance LGBTQ+ Health and Well-Being (July 2021)
• The Evolution of Compliance in the Life Sciences Industry – A Discussion with the Chief Compliance Officers of Alexion and Otsuka (June 2021)
• The First 100 Days as CLO: How to Ensure Success (May 2021)